✅ #Rosacea versus #LUPUS ⬇️
Practical tips for distinguishing the 2 conditions 👍

Recent additions to the ASAS slide library: summaries of bimekizumab (anti IL-17A and IL-17F biologic) trials,
BE MOBILE 1 and BE MOBILE 2, in non-radiographic & radiographic axial SpA

See more slides here: asas-group.org/education/asas…

Are you an early career researcher looking to enhance your review skills?

If you have a special interest in Spondyloarthritis, I would be delighted to team up 👯‍♂️ with you in a mentor-mentor partnership! 🤝

Find more details below 👇🏻

Congrats Laurent ARNAUD & team!

🗞️ What's in the current Annals' issue?

Shift in perspective: autoimmunity protecting against #rheumatoid arthritis

🔎 What if the ACPAs are protective in pre-RA instead of pathogenic?

👉 Check out the interesting insights in
ard.bmj.com/content/83/5/5…

#antibodies

📢 Join us on April 24, 2024, for the ArLAR Young Rheumatologists Group Webinar: 'Challenging Cases, Rheumatoid Arthritis and Beyond'.

🔗 Register now: us02web.zoom.us/webinar/regist…

#rheumatology #ArLAR #rheumatoidarthritis #Rheumatologist #webinar

Disentangling the riddle of #SLE with #APS

Blood transcriptome analysis reveals a less pronounced IFN-signature and distinct molecular profiles in venous versus arterial events

🔬 Whole-blood RNA-sequencing
⭐ 299 SLE (108 SLE-aPL+)
⭐72 matched HC

👉 bit.ly/3PWPgCb

Share your knowledge and practices on axSpA!

Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis

🔬 A study based three complementary mouse models

👉 bit.ly/4cTDT85

#systemic_sclerosis
#animal_models

📣Have your say on #axSpA !
Please compile & share this interesting survey! 📝
It takes only 5 minutes 🤗

SIRyoung AG Junge Rheumatologie PANLAR joven JOVREUM EMEUNET Latika Dr. Fabian Proft Nelly ZIADE 🍀

Modulation of immunological pathways by Type I interferon blockade with #anifrolumab in the 🌷1 and 🌷🌷2 trials in #lupus .

ard.bmj.com/content/early/…

Metabolic changes in sera of patients with #rheumatoidarthritis or #spondyloarthropathies are indicative of cancer or paraneoplastic syndroms, a new study from 🇩🇪 shows. Will it facilitate an earlier diagnosis of #cancer in this population?

🔗 bit.ly/3TAsSje

🤔 Is specific #Tcell receptor blockade a new treatment avenue in #spondyloarthritis ? ☝️ Read what the experts think in this 'Views on news' article ard.bmj.com/content/early/…

🎯Connecting #osteoarthritis genetic risk loci with genes in chondrocytes highlights PAPPA and SPRY4 as interesting novel effector genes in OA🙌
👉 the whole dataset is available in an open repository for others to dig in #NCBI GSE260760👍
ard.bmj.com/content/early/…

📣 Safety of #JAKi or #TNFi in rheumatoid #arthritis and #spondyloarthritis ::
🔹 6826 real-world patients: 52% RA, 25% PsA, 23% axSpA
🔸 IRR of infections and GI events higher with JAKi ❗JAKi were prescribed in patients with poorer prognosis❗
bit.ly/3PVVoLe

🤔 What is worse for #cardiovascular disease in ankylosing #spondylitis - continuous low or intermittent high #NSAIDs ?
🔷 19706 Korean patients studied
🔶 higher dose of NSAID treatment was associated with a higher risk of CVD❗
ard.bmj.com/content/early/…

Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies
By The CoVAD Study
Via Rheumatology International
Congratulations friends 👏🏼🥳🎉
link.springer.com/article/10.100…

Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients
ASAS Olena Zimba Nelly ZIADE 🍀 Burhan Fatih Koçyiğit
link.springer.com/article/10.100…

✔️ The Outcome Measures in Rheumatology ( #OMERACT ) Ultrasound Working Group generated a consensus-driven ultrasound dactylitis score for psoriatic #arthritis 😍🖐️ =GLobal OMERACT Ultrasound DActylitis Score (GLOUDAS)👍 see the details here 👉ard.bmj.com/content/early/…

Our study in @BrainComms 🔥
94 pts with #Mitochondrial #myopathy
Common features regardless of geno/phenotype:
1️⃣slow progression
2️⃣high morbidity&mortality⚠️
3️⃣main risk factor🫀

New 💊 urgently needed‼️
Timely diagnosis is 🗝️
👀 for complications

academic.oup.com/braincomms/art…